The Chemours Company EPS (Earnings per Share) 2013–2025
The Chemours Company reported $-2.57 of earnings per share for fiscal 2025. That was 658.7% lower than fiscal 2024. Compared with fiscal 2020, the change was -294.7%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $-2.57 | -658.7% |
| FY 2024 | $0.46 | +127.1% |
| FY 2023 | $-1.70 | -146.6% |
| FY 2022 | $3.65 | +1.4% |
| FY 2021 | $3.60 | +172.7% |
| FY 2020 | $1.32 | +512.5% |
| FY 2019 | $-0.32 | -105.9% |
| FY 2018 | $5.45 | +39.4% |
| FY 2017 | $3.91 | +9675.0% |
| FY 2016 | $0.04 | +108.0% |
| FY 2015 | $-0.50 | -122.6% |
| FY 2014 | $2.21 | -5.6% |
| FY 2013 | $2.34 | — |
Source: The Chemours Company SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CC 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
The Chemours Company reported $-2.57 of earnings per share for fiscal 2025. That was 658.7% lower than fiscal 2024. Compared with fiscal 2020, the change was -294.7%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for The Chemours Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeThe Chemours Company — frequently asked questions
What is The Chemours Company's earnings per share?
The Chemours Company (CC) reported earnings per share of $-2.57 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from The Chemours Company's official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.